Live feed
Filing
SC 13G/A
SC 13G/A0001590144-23-000009·Insight Molecular Diagnostics Inc.
Schedule 13G ownership disclosure
ONCOCYTE CORPORATION
Security class unavailable · CUSIP: 68235C107
Event date: 2022-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 18,056,274
- Percent of class
- 15.2200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001590144-23-000009
- Form type
- SC 13G/A
- Filer
- Insight Molecular Diagnostics Inc.
- CIK
- CIK 1642380
- Filed
- Feb 14, 2023
- Reporting period
- Dec 31, 2022
- Description
- Schedule 13G beneficial ownership